Challenging anesthesia of the patient on ketogenic diet therapy scheduled for scoliosis surgery under motor evoked potentials monitoring: a case report

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F23%3A00078311" target="_blank" >RIV/65269705:_____/23:00078311 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/23:00131447

Výsledek na webu

<a href="https://link.springer.com/article/10.1007/s00540-023-03226-z" target="_blank" >https://link.springer.com/article/10.1007/s00540-023-03226-z</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s00540-023-03226-z" target="_blank" >10.1007/s00540-023-03226-z</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Challenging anesthesia of the patient on ketogenic diet therapy scheduled for scoliosis surgery under motor evoked potentials monitoring: a case report

Popis výsledku v původním jazyce

Although propofol represents a &quot;gold standard&quot; from anesthetic drugs for total intravenous anesthesia (TIVA) with intraoperative neurophysiological monitoring (IONM), the anesthetic team should have an alternative plan in rare cases when the propofol is contraindicated, and remimazolam, a new ultra-short-acting benzodiazepine, is not available [1, 2]. We describe a patient suffering from glucose transporter type 1 deficiency syndrome (Glut1DS) with the history of epilepsy treated by ketogenic diet therapy (KDT) scheduled for scoliosis surgery under IONM. The prolonged propofol administration was contraindicated due to high doses of carbohydrates contained in propofol that may worsen epilepsy. In rare cases, prolonged propofol infusion can lead to propofol infusion syndrome (PRIS) in patients on KDT, and that is why anesthetic team has to prepare an alternative management to allow quality IONM

Název v anglickém jazyce

Challenging anesthesia of the patient on ketogenic diet therapy scheduled for scoliosis surgery under motor evoked potentials monitoring: a case report

Popis výsledku anglicky

Although propofol represents a &quot;gold standard&quot; from anesthetic drugs for total intravenous anesthesia (TIVA) with intraoperative neurophysiological monitoring (IONM), the anesthetic team should have an alternative plan in rare cases when the propofol is contraindicated, and remimazolam, a new ultra-short-acting benzodiazepine, is not available [1, 2]. We describe a patient suffering from glucose transporter type 1 deficiency syndrome (Glut1DS) with the history of epilepsy treated by ketogenic diet therapy (KDT) scheduled for scoliosis surgery under IONM. The prolonged propofol administration was contraindicated due to high doses of carbohydrates contained in propofol that may worsen epilepsy. In rare cases, prolonged propofol infusion can lead to propofol infusion syndrome (PRIS) in patients on KDT, and that is why anesthetic team has to prepare an alternative management to allow quality IONM

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30223 - Anaesthesiology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Anesthesia

ISSN

0913-8668

e-ISSN

1438-8359

Svazek periodika

37

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

JP - Japonsko

Počet stran výsledku

3

Strana od-do

815-817

Kód UT WoS článku

001045109800001

EID výsledku v databázi Scopus

2-s2.0-85167341613